<?xml version="1.0" encoding="UTF-8"?>
<ref id="B84-vaccines-07-00074">
 <label>84.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Doria-Rose</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Georgiev</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Oâ€™Dell</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chuang</surname>
    <given-names>G.Y.</given-names>
   </name>
   <name>
    <surname>Staupe</surname>
    <given-names>R.P.</given-names>
   </name>
   <name>
    <surname>McLellan</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Gorman</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pancera</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bonsignori</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Haynes</surname>
    <given-names>B.F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies</article-title>
  <source>J. Virol.</source>
  <year>2012</year>
  <volume>86</volume>
  <fpage>8319</fpage>
  <lpage>8323</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00696-12</pub-id>
  <pub-id pub-id-type="pmid">22623764</pub-id>
 </element-citation>
</ref>
